Open AccessComparison of Bioavailability and Bioequivalence of Generic and Brand Name Formulations of Escitalopram Oxalate Tablets in Healthy Chinese Population Under Fasting and Fed Conditions
Author(s) -
Qiuying Li,
Hua Huo,
Junliang Yuan,
Yin Shen,
Yaning Tang
Publication year - 2020
Publication title -
drug design, development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s271970
Subject(s) - bioequivalence , escitalopram , bioavailability , pharmacokinetics , tolerability , cmax , medicine , crossover study , confidence interval , pharmacology , adverse effect , generic drug , placebo , drug , alternative medicine , pathology , hippocampus , antidepressant
This study compared the bioequivalence of two formulations of escitalopram oxalate 20 mg tablets in terms of bioavailability and tolerability in healthy Chinese male and female subjects.